PubMed · 1991 · 112 citations · 0 references
MedicineOncologyPreventive MedicineCancer ControlCancer PreventionCancer ScreeningCancer BiomarkersCancer RiskEarly Cancer DetectionTumor MarkersAssayBiomarkers Of Cancer RiskDetectionHigh-risk Group ScreeningSerum BiomarkersSerum SamplingSerum Tumor MarkersTumor Marker Assays
Studies were performed on cancer detection and prevention in the high cancer risk group. To improve the screening method in the diagnosis of unspecified cancer, a modified combination assay was devised using a combination of several tumor markers and adding risk factors of malignancies obtainable from blood samples. Five tumor markers, AFP, CEA, CA 19-9, DUPAN-2 and CA 125 were determined simultaneously in each serum sample obtained from 54 patients with various cancer diseases. A modified combination assay was also examined using the risk factors of malignancies, pepsinogen I/II ratio together with 5 tumor markers. Detection rate was elevated to 68.5% by a combination assay using 5 tumor markers. Detection rate by modified combination assay using the risk factor (pepsinogen I/II ratio) together with 5 tumor markers was further improved to 88.8% without decreasing the specificity. The modified combination assay is easy in practice and expected to contribute in the screening of unspecified cancer diseases.